# Function Health Secures $450M Growth Round from General Catalyst

> Function Health, a startup that blends lab testing, imaging, and AI analysis into a subscription for preventive care, has raised a 450 million dollar growth round led by General Catalyst's Customer Value Fund. The deal arrives only eight months after a 298 million dollar Series B and brings the company's total to more than 800 million dollars since it launched in 2023. The product is straightforward to grasp: memberships start around 365 dollars a year for more than 160 tests, with software layered on top to interpret results and flag issues early. Function says it has crossed a million members, and the raise is meant to fund expansion of that preventive-health model. The bet reflects a broader wave of money flowing into consumer health startups that wrap AI around diagnostics. The promise is catching problems sooner and making dense lab data legible to ordinary people. The open questions, as always with self-directed testing, are how much of it changes outcomes versus how much simply generates more anxiety and follow-up appointments.

_Section: [AI Funding Tracker](https://www.wortins.com/funding) · Source: MobiHealthNews · Published Friday, August 21, 2026_

## Wortins' read

Function Health, a startup that blends lab testing, imaging, and AI analysis into a subscription for preventive care, has raised a 450 million dollar growth round led by General Catalyst's Customer Value Fund. The deal arrives only eight months after a 298 million dollar Series B and brings the company's total to more than 800 million dollars since it launched in 2023. The product is straightforward to grasp: memberships start around 365 dollars a year for more than 160 tests, with software layered on top to interpret results and flag issues early. Function says it has crossed a million members, and the raise is meant to fund expansion of that preventive-health model. The bet reflects a broader wave of money flowing into consumer health startups that wrap AI around diagnostics. The promise is catching problems sooner and making dense lab data legible to ordinary people. The open questions, as always with self-directed testing, are how much of it changes outcomes versus how much simply generates more anxiety and follow-up appointments.

## Source

[Read the full story at MobiHealthNews](https://www.mobihealthnews.com/news/function-health-secures-450m-growth-financing)

## Related coverage

- [Moonshot AI Releases Kimi K3, World's Largest Open-Source AI Model at 2.8 Trillion Parameters](https://www.wortins.com/story/moonshot-ai-releases-kimi-k3-world-s-largest-open-source-ai--cde823ba) — [Tom's Hardware](https://www.tomshardware.com/tech-industry/artificial-intelligence/moonshot-releases-2-8-trillion-parameter-kimi-k3)
- [Hey Noah](https://www.wortins.com/story/hey-noah-c9c72973) — [Futurepedia](https://futurepedia.io/)
- [Cohere Launches Command A+ Mixture-of-Experts Model](https://www.wortins.com/story/cohere-launches-command-a-mixture-of-experts-model-5d840970) — [Cohere](https://docs.cohere.com/docs/command-a-plus)
- [Stripe Acquires OpenRouter for $7B+](https://www.wortins.com/story/stripe-acquires-openrouter-for-7b-2abe2a10) — [TechCrunch](https://techcrunch.com/2026/08/16/stripe-will-reportedly-acquire-ai-gateway-startup-openrouter-for-7b/)
- [Hike Medical Raises $22.5 Million Across Seed and Series A Funding](https://www.wortins.com/story/hike-medical-raises-22-5-million-across-seed-and-series-a-fu-111e6a0a) — [TechStartups](https://techstartups.com/2026/08/26/startup-funding-news-today-august-26-2026-emerald-ai-gatik-stellaria-more/)
- [Callosum Raises $100 Million to Match AI Tasks with Most Cost-Effective Models](https://www.wortins.com/story/callosum-raises-100-million-to-match-ai-tasks-with-most-cost-da05cef6) — [Bloomberg](https://www.bloomberg.com/news/articles/2026-08-20/ai-startup-callosum-raises-100-million-to-make-ai-tasks-cheaper)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._
